THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES

使用纤维蛋白特异性抗体检测血栓

基本信息

  • 批准号:
    3339435
  • 负责人:
  • 金额:
    $ 22.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-01-01 至 1992-12-31
  • 项目状态:
    已结题

项目摘要

Current methods for in vivo thrombus detection either lack specificity or pose additional health risks. With the tools of molecular immunology and syntheitic peptide chemistry, we plan to prepare a clinically useful, diagnostic antibody that possesses specificity for human fibrin (the structural protein in thrombi) and provides sufficient sensitivity for in vivo thrombus detection by gamma scintigraphy. Our strategy will emphasize the differences between fibrin and its soluble precursor, fibrinogen, and will focus on ways to select fibrinspecific antibodies. Synthetic peptides will be designed to mimic fibrinunique epitopes and used to elicit antibodies that will bind human fibrin in the presence of fibrinogen. This approach was validated during the previous grant period when we used a synthetic peptide corresponding to the N terminus of the human fibrin beta-chain to elicit monoclonal antibodies that bound to fibrin monomer in the presence of fibrinogen. The in vivo specificity of one monoclonal antibody (64C5) was confirmed in experiments using chicken, rabbit and dog models. In the research proposed here, we focus on the design and testing of various fibrin-like peptides corresponding to thrombin cleavage sites and Factor XIIIa cross-link sites, and describe plans for an improved screening strategy that uses fibrin miniclots rather than fibrin monomers as antigens. Our specific aims include the in vivo testing of antibody 5D7 as a gamma scintigraphic agent for detecting experimental thrombi; the preparation of monoclonal antibodies that avidly bind to clotted fibrin; the synthesis and refinement of cross-link antigens related to gamma-chain cross-link sites; and the structural and immunochemical study of the alpha-chain cross-link site in order to identify a new fibrin-unique epitope. Three specific benefits will result from these experiments: First, they will provide a detailed immunochemical analysis of unique epitopes on the fibrin molecule. They will also suggest general methods for differentiating any protein from its precursor. Second, they will provide reagents that can tag thrombi in vivo. Third, they will lay the foundation upon which a sensitive and specific noninvasive test for life-threatening thromboembolism can be built.
目前体内血栓检测方法缺乏

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation.
血小板结合纤维蛋白原的 γ 链羧基末端上的 AGDV 残基是血小板聚集所必需的。
  • DOI:
    10.1016/s0167-4838(97)00130-1
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Liu,Q;Matsueda,G;Brown,E;Frojmovic,M
  • 通讯作者:
    Frojmovic,M
Immunodetection of human fibrin using monoclonal antibody-64C5 in an extracorporeal chicken model.
在体外鸡模型中使用单克隆抗体 64C5 进行人纤维蛋白的免疫检测。
  • DOI:
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Hui,KY;Haber,E;Matsueda,GR
  • 通讯作者:
    Matsueda,GR
Bispecific Monoclonal Antibodies Produced by Somatic Cell Fusion Increase the Potency of Tissue Plasminogen Activator
体细胞融合产生的双特异性单克隆抗体可提高组织纤溶酶原激活剂的效力
  • DOI:
    10.1055/s-0038-1647297
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    E. Branscomb;M. Runge;C. Savard;Keith Adams;G. Matsueda;E. Haber
  • 通讯作者:
    E. Haber
Characterization of a monoclonal antibody directed against the carboxyl-terminus of human factor XIII. An epitope exposed upon denaturation and conserved across species lines.
针对人因子 XIII 羧基末端的单克隆抗体的表征。
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Song,Y;Taubenfeld,SM;Sheng,D;Matsueda,GR
  • 通讯作者:
    Matsueda,GR
Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin.
α2-抗纤溶酶抗体加速血浆凝块溶解。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY R MATSUEDA其他文献

GARY R MATSUEDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY R MATSUEDA', 18)}}的其他基金

THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339434
  • 财政年份:
    1990
  • 资助金额:
    $ 22.51万
  • 项目类别:
THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339433
  • 财政年份:
    1990
  • 资助金额:
    $ 22.51万
  • 项目类别:
THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339432
  • 财政年份:
    1988
  • 资助金额:
    $ 22.51万
  • 项目类别:
THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339429
  • 财政年份:
    1988
  • 资助金额:
    $ 22.51万
  • 项目类别:
THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339428
  • 财政年份:
    1982
  • 资助金额:
    $ 22.51万
  • 项目类别:
THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339431
  • 财政年份:
    1982
  • 资助金额:
    $ 22.51万
  • 项目类别:
THROMBUS DETECTION USING FIBRIN-SPECIFIC ANTIBODIES
使用纤维蛋白特异性抗体检测血栓
  • 批准号:
    3339430
  • 财政年份:
    1982
  • 资助金额:
    $ 22.51万
  • 项目类别:
CHEMICAL SEMI-SYNTHESIS OF DIGOXIN-SPECIFIC ANTIBODY
地高辛特异性抗体的化学半合成
  • 批准号:
    4695520
  • 财政年份:
  • 资助金额:
    $ 22.51万
  • 项目类别:

相似海外基金

Optimising antibody specificity and efficacy through Fc engineering
通过 Fc 工程优化抗体特异性和功效
  • 批准号:
    BB/N503927/1
  • 财政年份:
    2015
  • 资助金额:
    $ 22.51万
  • 项目类别:
    Training Grant
Integrating Experiment and Theory to Characterize Diagnostic Antibody Specificity
结合实验和理论来表征诊断抗体特异性
  • 批准号:
    7994664
  • 财政年份:
    2010
  • 资助金额:
    $ 22.51万
  • 项目类别:
Integrating Experiment and Theory to Characterize Diagnostic Antibody Specificity
结合实验和理论来表征诊断抗体特异性
  • 批准号:
    8136201
  • 财政年份:
    2010
  • 资助金额:
    $ 22.51万
  • 项目类别:
Integrating Experiment and Theory to Characterize Diagnostic Antibody Specificity
结合实验和理论来表征诊断抗体特异性
  • 批准号:
    8324720
  • 财政年份:
    2010
  • 资助金额:
    $ 22.51万
  • 项目类别:
Integrating Experiment and Theory to Characterize Diagnostic Antibody Specificity
结合实验和理论来表征诊断抗体特异性
  • 批准号:
    8537214
  • 财政年份:
    2010
  • 资助金额:
    $ 22.51万
  • 项目类别:
Integrating Experiment and Theory to Characterize Diagnostic Antibody Specificity
结合实验和理论来表征诊断抗体特异性
  • 批准号:
    8328875
  • 财政年份:
    2010
  • 资助金额:
    $ 22.51万
  • 项目类别:
Quantitative Serum Antibody Specificity Screening in Celiac Disease
乳糜泻血清抗体特异性定量筛查
  • 批准号:
    7531456
  • 财政年份:
    2008
  • 资助金额:
    $ 22.51万
  • 项目类别:
Quantitative Serum Antibody Specificity Screening in Celiac Disease
乳糜泻血清抗体特异性定量筛查
  • 批准号:
    7673756
  • 财政年份:
    2008
  • 资助金额:
    $ 22.51万
  • 项目类别:
CARBOHYDRATES AND GLYCOPROTEINS IN ANTIBODY SPECIFICITY AND EFFECTOR MECHANISMS
抗体特异性和效应机制中的碳水化合物和糖蛋白
  • 批准号:
    6978238
  • 财政年份:
    2004
  • 资助金额:
    $ 22.51万
  • 项目类别:
HLA-D antigens, T cell epitopes and antibody specificity in SLE
SLE 中的 HLA-D 抗原、T 细胞表位和抗体特异性
  • 批准号:
    6663942
  • 财政年份:
    2002
  • 资助金额:
    $ 22.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了